
APN · Aspen Pharmacare Holdings Limited
156.70
ZARUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
R67.78B
PE
240.20
EV/EBITDA
9.6
DIV Yield
1.5%
Payout Ratio
200%
MQV Rating
4Weak
As at 16/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- HALO 100
- HALO 200
- HALO 50
- HALO All
Key Fundamentals
EPS 3 yr Growth
-94.50%
EBITDA Margin
20.60%
Operating Cashflow
R6,869m
Free Cash Flow Return
6.70%
ROIC
-0.90%
Interest Coverage
4.70
Quick Ratio
1.70
Performance
52 weeks range
Low 90.7 - 166.21
Trade Value (12mth)
US$2,480,411.00
1 week
-1.35%
1 month
0.13%
YTD
38.03%
1 year
51.49%
All time high
448.68
Additional Data
Shares Outstanding (Fully Diluted)
443m
HALO Sector
Healthcare
Next Company Report Date
01-Sep-27
Next Ex Dividend Date
07-Oct-26
Next Dividend Pay Date
12-Oct-26
Reporting Currency
ZAR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Weak
Garp
Weak
Mqv Small
Neutral
Momentum
Price
Neutral
Earnings
Very Weak
Growth
Earnings
Strong
Dividends
Neutral
Quality
Capital Efficiency
Very Weak
Balance Sheet
Strong
Valuation
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Stephen Bradley Saad | Individual |
| Michael Guy Attridge | Individual |
| Ceppwawu Investments (Pty) Ltd. | Private Company |
| Aspen Share Incentive Trust | Emp Stk Ownership Plan |